SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,774 | -62.1% | 15,031 | -23.7% | 0.00% | – |
| Q2 2023 | $94,397 | -94.2% | 19,707 | -92.2% | 0.00% | -100.0% |
| Q3 2022 | $1,630,000 | +35.3% | 253,919 | -27.7% | 0.00% | +33.3% |
| Q2 2022 | $1,205,000 | -36.5% | 351,312 | +31.9% | 0.00% | -25.0% |
| Q1 2022 | $1,897,000 | +391.5% | 266,408 | +475.4% | 0.00% | +300.0% |
| Q4 2021 | $386,000 | -40.6% | 46,299 | -50.4% | 0.00% | 0.0% |
| Q3 2021 | $650,000 | -11.7% | 93,332 | +202.4% | 0.00% | 0.0% |
| Q2 2021 | $736,000 | +74.0% | 30,862 | +50.4% | 0.00% | 0.0% |
| Q1 2021 | $423,000 | -60.3% | 20,522 | -52.8% | 0.00% | -50.0% |
| Q4 2020 | $1,066,000 | -38.0% | 43,513 | -28.4% | 0.00% | -33.3% |
| Q3 2020 | $1,720,000 | +248.2% | 60,754 | -57.6% | 0.00% | +200.0% |
| Q4 2019 | $494,000 | -47.6% | 143,140 | -39.0% | 0.00% | 0.0% |
| Q3 2019 | $942,000 | – | 234,841 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |